D. Domin et al. / Journal of Organometallic Chemistry 692 (2007) 1048–1057
1055
(s), 31.0 (t), 25.4 (t), 20.0 (q). Anal. Calc. for
C23H28Cl2N2Pd: C, 54.19; H, 5.54; N, 5.50. Found: C,
54.24; H, 5.46; N, 5.60%.
was added and the mixture was refluxed for 2 h. The sol-
vent was removed under vacuum and the resulting beige
solid was collected on a glass frit and washed twice with
Et2O (10 mL). Yield: 0.64 g (86%). Mp: decomp. >200–
1
3.3.2. Pd{N,N0-(1,1-Cyclopentylidenedimethylidyne)-
bis((R)-a-methylbenzenemethanamine)}Cl2 (8b)
204 ꢁC. H NMR (CDCl3): d 7.46–7.02 (m, 12H, HAr and
CHN), 5.90 (bs, 2H, CH), 2.99–2.45 (m, 2H, CH2), 2.02–
1.05 (m, 12H, CH2 and CH3). 13C{1H} NMR (CDCl3): d
169.7 (d), 138.9 (s), 129.2 (d), 128.7 (d), 128.4 (d), 67.5
(d), 60.4 (s), 29.7 (t), 25.5 (t), 20.2 (q). Anal. Calc. for
C23H28Br2N2Pd: C, 46.14; H, 4.71; N, 4.68. Found: C,
46.20; H, 4.66; N, 4.75%.
Pd(COD)Cl2 (213 mg, 0.75 mmol) and 1b (250 mg,
0.75 mmol) gave analogously to the procedure described
for 8a a yellow solid. Yield: 320 mg (84%). 1H NMR
(CD2Cl2): d 7.38–7.35 (m, 6H, HAr), 7.28–7.25 (m, 4H,
HAr), 7.08 (s, 2H, CHN), 5.79 (q, J = 6.7 Hz, 2H, CH),
2.69–2.66 (m, 4H, CH2), 1.83–1.77 (m, 4H, CH2), 1.40 (d,
J = 6.9 Hz, 6H, CH3). 13C{1H} NMR (CD2Cl2): d 170.1
(d), 139.0 (s), 129.1 (d), 128.7 (d), 128.3 (d), 66.3 (d), 60.1
(s), 39.6 (t), 25.4 (t), 20.0 (q). Anal. Calc. for
C23H28Cl2N2Pd: C, 54.19; H, 5.54; N, 5.50. Found: C,
54.30; H, 5.68; N, 5.47%.
3.3.6. Pd{N,N0-((2R,5R)-2,5-Diphenyl-1,1-
cyclopentylidenedimethylidyne)bis(2,6-dimethyl-
benzenamin)}Cl2 (9a)
A suspension of PdCl2 (62.1 mg, 0.35 mmol) in acetoni-
trile (6 mL) was refluxed until a clear orange solution of
Pd(CH3CN)2Cl2 was formed. 7a (0.17 g, 0.35 mmol) was
then added whereupon the color of the solution changed
from orange to yellow. After the mixture was refluxed
for 2 h, the solvent was removed under vacuum and the
resulting yellow solid was collected on a glass frit and
washed twice with Et2O (5 mL). Yield: 0.23 g (99%).
Mp: decomp. >240 ꢁC. 1H NMR (CDCl3): d 7.40–7.10
(m, 12H, HAr and CHN), 6.96–6.67 (m, 6H, HAr), 4.06
(bs, 2H, CH), 2.55–2.35 (m, 4H, CH2), 2.22 (s, 6H,
CH3), 1.34 (s, 6H, CH3). 13C{1H} NMR (CDCl3): d
172.1 (d), 148.7 (s), 136.2 (s), 129.8 (s), 129.7 (s), 129.5
(d), 128.5 (d), 128.3 (d), 127.8 (d), 127.7 (d), 126.8 (d),
67.0 (s), 56.3 (d), 31.2 (t), 19.6 (q), 17.7 (q). Anal. Calc.
for C36H36Cl2N2Pd: C, 64.15; H, 5.38; N, 4.16. Found:
C, 63.98; H, 5.12; N, 4.25%.
3.3.3. Pd{N,N0-(1,1-Cyclopentylidenedimethylidyne)-
bis((S)-a-(methoxymethyl)benzeneethanamine)}Cl2 (8c)
Pd(COD)Cl2 (270 mg, 0.95 mmol) and 1c (400 mg,
0.95 mmol) gave analogously to the procedure described
for 8a a yellow solid. Yield: 450 mg (80%). 1H NMR
(CD2Cl2): d 7.34–7.25 (m, 12H, HAr and CHN), 4.77 (bs,
2H, CH), 3.71 (dd, J = 10.7 Hz, 2.7 Hz, 1H, CH2), 3.57
(dd, J = 10.7 Hz, 4.8 Hz, 1H, CH2), 3.40 (dd,
J = 13.5 Hz, 6.4 Hz, 1H, CH2), 3.31 (s, 6H, OCH3), 2.92
(dd, J = 13.5 Hz, 9.1 Hz, 1H, CH2), 2.62–2.54 (m, 4H,
C(CH2CH2)2), 1.76–1.67 (m, 4H, C(CH2CH2)2). 13C{1H}
NMR (CD2Cl2): d 174.2 (d), 137.1 (s), 129.4 (d), 128.6
(d), 126.8 (d), 70.9 (t), 69.2 (d), 60.4 (s), 58.6 (q), 39.6 (t),
36.9 (t), 30.9 (t), 25.1 (t). Anal. Calc. for
C25H32Cl2N2O2Pd: C, 52.69; H, 5.66; N, 4.92. Found: C,
52.78; H, 5.56; N, 5.10%.
3.3.7. Pd{N,N0-((2R,5R)-2,5-Diphenyl-1,1-
cyclopentylidenedimethylidyne)bis((S)-a-
methylbenzenemethanamine)}Cl2 (9b)
3.3.4. Pd{N,N0-(1,1-Cyclopentylidenedimethylidyne)-
bis((R)-a(methoxymethyl)benzeneethanamine)}Cl2 (8d)
Pd(COD)Cl2 (170 mg, 0.60 mmol) and 1d (250 mg,
0.60 mmol) gave analogously to the procedure described
for 8a a yellow solid. Yield: 250 mg (70%). 1H NMR
(CD2Cl2): d 7.33–7.25 (m, 12H, HAr and CHN), 4.77
(bs, 2H, CH), 3.72 (dd, J = 10.7 Hz, 2.7 Hz, 1H, CH2),
3.57 (dd, J = 10.7 Hz, 4.6 Hz, 1H, CH2), 3.42 (dd,
J = 13.2 Hz, 6.4 Hz, 1H, CH2), 3.31 (s, 6H, OCH3),
2.92 (dd, J = 13.2 Hz, 8.9 Hz, 1H, CH2), 2.63–2.61 (m,
4H, C(CH2CH2)2), 1.76–1.67 (m, 4H, C(CH2CH2)2).
13C{1H} NMR (CD2Cl2): d 174.2 (d), 137.1 (s), 129.4
(d), 128.6 (d), 126.8 (d), 70.9 (t), 69.1 (d), 60.5 (s), 58.6
(q), 39.6 (t), 36.9 (t), 25.1 (t). Anal. Calc. for
C25H32Cl2N2O2Pd: C, 52.69; H, 5.66; N, 4.92. Found:
C, 52.61; H, 5.72; N, 4.87%.
PdCl2 (55.0 mg, 0.31 mmol) and 7b (0.15 g, 0.31 mmol)
gave analogously to the procedure described for 9a a
beige solid. Yield: 0.20 g (99%). Mp: decomp. >210 ꢁC.
1H NMR (CDCl3): d 7.50–7.11 (m, 16H, HAr and
CHN), 6.99–6.64 (m, 6H, HAr), 5.93–5.67 (m, 2H, CH),
4.42 (bs, 2H, CH), 2.82–2.35 (m, 4H, CH2), 1.19 (d,
J = 6.9 Hz, 6H, CH3). 13C{1H} NMR (CDCl3): d 166.9
(d), 138.0 (s), 137.5 (s), 128.9 (d), 128.6 (d), 128.4 (d),
128.3 (d), 127.8 (d), 127.7 (d), 67.3 (s), 66.8 (d), 54.5
(d), 29.9 (t), 19.5 (q). Anal. Calc. for C36H36Cl2N2Pd:
C, 64.15; H, 5.38; N, 4.16. Found: C, 64.20; H, 5.42;
N, 4.25%.
3.3.8. Pd{N,N0-((2R,5R)-2,5-Diphenyl-1,1-cyclo-
pentylidenedimethylidyne)bis((R)-a-methylbenzene-
methanamine)}Cl2 (9c)
3.3.5. Pd{N,N0-(1,1-Cyclopentylidenedimethylidyne)-
bis((R)-a-methylbenzenemethanamine)}Br2 (8e)
A suspension of PdBr2 (0.32 g, 1.23 mmol) in CH3CN
PdCl2 (72.7 mg, 0.41 mmol) and 7c (0.20 g, 0.41 mmol)
gave analogously to the procedure described for 9a a
beige solid. Yield: 0.27 g (99%). Mp: decomp. >120 ꢁC.
1H NMR (CDCl3): d 7.43–7.08 (m, 16H, HAr and
CHN), 7.07–6.80 (m, 6H, HAr), 5.85 (q, J= 6.7 Hz, 2H,
(20 mL) was refluxed until
a
clear solution of
Pd(CH3CN)2Br2 was formed. Then 1a (0.41 g, 1.23 mmol)